Bovine growth hormone was given daily for 10 days to female Sprague\x=req-\ Dawley rats hypophysectomized at the age of 60 days, beginning 15 days post-operatively. Longitudinal bone growth, studied in the proximal tibia, was reactivated and continued at an accelerating rate during the period of hormone administration and for a further 5 days after its withdrawal, but then ceased.
1965; Evans et al. 1966; Urist 1972 ). This effect on the longitudinal bone growth is dependent on the dose and the length of the administration period (Thorngren et al. 1973& ).
The present investigation was made to determine the effect of withdrawal of growth hormone administration on the longitudinal bone growth in the hypophysectomized rat. With tetracycline as an intravital marker of the longi¬ tudinal bone growth from the proximal growth plate of the tibia, this effect was determined during various periods after the cessation of growth hormone administration. The width of the growth plate of proximal tibia as well as the size of its degenerative cells, and the weight of body and heart were also studied to compare the changes in different growth parameters. The cell pro¬ duction in the proximal growth plate of the tibia was calculated to analyse whether the changes in longitudinal bone growth were due mainly to changes in the cell production or in the size of the degenerative cell in the growth plate.
MATERIAL AND METHODS
Female Sprague-Dawley rats with known date of birth (day of birth registered as day 1) were delivered from the breeding farm (Mollegaard, Denmark) one week before hypophysectomy. The animals were kept in clear plastic cages with a metal grill top in an air-conditioned room with daylight illumination. The temperature was 22-24°C and the relative humidity 40-50°/o. On arrival and during the experiments, the general condition of the animals was controlled and the weight was registered. All the animals were given pellets (Anticimex 213) and water ad libitum; 150 animals were hypophys¬ ectomized at 60 days of age; 70 survived the investigation period.
The rats were hypophysectomized by the parapbaryngeal approach (Smith 1930; Thorngren et al. 1973 ) and after a post-operative control period of 15 days, the ad¬ ministration of growth hormone was started. The animals were given one daily sc injection of 25 µg bovine growth hormone (NIH-GH-B15) obtained from National Institutes of Health, USA. This was dissolved in saline and a new solution prepared each day. Two groups of animals were given NIH-GH-B15 for 5 or 10 days and killed on the day after the last administration. Three other groups of animals were given growth hormone for 10 days and were thereafter kept for a further 5, 10 or 15 days before being killed. One group of control animals was killed 15 days postoperatively when the growth hormone administration for the other groups was started. The other control values were taken from Thorngren et al. (1913b) .
To determine the accumulated growth in length, the experimental animals were given two consecutive doses (10 mg/kg) of oxytetracycline, OTC (Terramycin®), intraperitoneally, and were anaesthetized with ether to increase the accuracy of the in¬ jections (Hansson et al. 1972 ). The animals were given two injections of OTC, the first at hypophysectomy and the second 15 days post-operatively. After the administra¬ tion of growth hormone and the observation period following withdrawal of the growth hormone administration, they were killed with ether. The accumulated growth in length was determined 0-15 days post-operatively and also during the whole period of growth hormone administration and the following withdrawal period. The group of animals killed 15 days post-operatively was only given one injection of OTC at hypophysectomy to determine the accumulated growth in length 0-15 days postoperatively.
The proximal tibia of the right side was dissected out and undecalcified sections were made according to a previously described method (Hansson 1964 (Hansson , 1967 from the medial part of the proximal tibia (Hansson et al. 1972 ). The growth determination was made with a fluorescence microscope with an error of method calculated to about 5 µ . (Hansson 1967; Hansson et al. 1972 ). The measurements were made between the two fluorescent bands corresponding to the injections of OTC, and between the second fluorescent band and the erosion line between metaphysis and growth plate (Thorngren et al. 1913b ). The width of the second fluorescent band was also determined (Thorn¬ gren et al. 1973 ). In the control animals killed 15 days post-operatively, the deter¬ mination was made between the fluorescent band and the erosion line.
In some instances, fluorescent bands were missing at the microscopical determination, as shown in earlier investigations with the use of intraperitoneal injection of OTC (Hansson et al. 1972) . In the present investigation, this was found in 7 animals, making it impossible to determine the post-operative accumulated growth in length during all the intended periods of observation. These animals were also excluded from the cal¬ culations of the other growth parameters.
Decalcified longitudinal and frontal sections of the left proximal tibia stained with haematoxylin and eosin were studied microscopically (Hansson 1967 ) with regard to the morphology of the growth plate. The growth plate was divided into different zones (Hansson 1967; Thorngren 8e Hansson, in press). The total width, the width of its un¬ differentiated zone and that of its columnar zone were determined as described by Hansson (1967) . The size of the degenerative cell situated close to the metaphysis in the growth plate was determined in press). The accumulated cell production in the proximal growth plate of the tibia was calculated from the ac¬ cumulated longitudinal bone growth divided by the size of the degenerative cell in press).
The completeness of the hypophysectomy was determined by microscopical examina¬ tion of serial sections of the sella turcica (Jacobsohn 1966 Effect of administration and withdrawal of growth hormone Growth in length.
After the administration of 25 µg NIH-GH-B15 daily for 5 or 10 days the accumulated growth in length of the proximal tibia in¬ creased with the period of administration. Animals given growth hormone had higher longitudinal bone growth than the controls. In the animals kept for various periods after the 10-day administration of growth hormone, the ac¬ cumulated growth in length was significantly higher than in animals killed on the day after the last injection of growth hormone (Fig. 1 Size of degenerative cell.
After the administration of growth hormone daily for 5 or 10 days, the size of the degenerative cell increased during 5 days administration and then remained constant after 10 days administration of growth hormone (Fig. 1, Table 1 ). Animals given growth hormone had bigger cells than the controls. During the withdrawal period after growth hormone administration, the cell size decreased somewhat ( Fig. L Table 1 ).
Cell production.
The accumulated cell production calculated from the accumulated longitudinal bone growth and the size of the degenerative cell showed changes similar to those described for the growth in length (Fig. 1 (Table 1) .
Body weight.
After the administration of growth hormone for 5 days, the body weight was unchanged as compared with the body weight at the start of the administration. After 10 days hormone administration, the body weight had increased and was higher than in the controls (Fig. 2, Table 1 ). During the 5-day withdrawal period after the growth hormone administration, the body weight decreased to almost its initial value. When the withdrawal period was increased, the body weight remained almost constant (Fig. 2, Table 1 ). The body weight of the controls showed only minor changes during the experimental period. Heart weight.
-
The weight of the heart ventricles showed the same changes as described for body weight (Fig. 2, Table 1 ). The ratio heart weight/body weight was almost constant for the various types of administration of growth hormone (Table 1) Sissons (1956 Sissons ( , 1971 , Hansson (1967) and Ham (1969) .
After 5 days administration of growth hormone, the width of the growth plate and the size of the degenerative cell had increased to their highest value ( Figs. 1 and 2) . A minor increase in the longitudinal bone growth and the cal¬ culated cell production was found, whereas the weight of the body and heart was unchanged (Figs. 1 and 2 ). The increase in the width of the growth plate depends on the increased cell proliferation and hypertrophy, whereas the ré¬ sorption of the cartilage cells at the erosion line is still rather low.
After 10 days administration of growth hormone, the width of the growth plate had decreased somewhat, and the size of the degenerative cell was un¬ changed. The longitudinal bone growth and the calculated cell production, however, had increased further. The body and heart had increased in weight and reached their highest values (Figs. 1 and 2 ). The decrease in the width of the growth plate is due to the increased activity in the résorption process of the degenerative cells at the erosion line.
When growth hormone administration was given for 10 days followed by a 5-day period after withdrawal of administration, the width of the growth plate remained constant, and the size of the degenerative cells was almost un¬ changed. The longitudinal bone growth and the calculated cell production in¬ creased further, both processes having accelerated ( Figs. 1 and 2 ). The weight of the body and heart had decreased to their initial values and then remained at a low level (Fig. 2) . Thus, an equilibrium had been achieved between the cell production in the growth plate and the cell destruction at the erosion line in the process of bone formation.
When the period after cessation of the growth hormone administration was increased to 10 days, the width of the growth plate decreased and reached the same value as the controls. The size of the degenerative cell decreased some¬ what further. The longitudinal bone growth and the calculated cell production showed a constant value as compared to the 5-day withdrawal period indicating that the bone growth had ceased. The decrease in the width of the growth plate and in the size of the degenerative cell reflects the cessation of cell prolifera¬ tion along with the decreasing résorption process.
With the 15-day withdrawal period, the effect was the same as for the 10-day withdrawal period.
Thus, the administration of growth hormone initiates a growth process in the different growth parameters studied. The time necessary to reach an op¬ timum growth effect was, however, found to differ for the growth parameters. After withdrawal of the growth hormone administration, the effect on the growth parameters studied also differed.
All the growth processes studied had stopped when the 10-day administra¬ tion period of growth hormone was followed by a withdrawal period of 10 days. The growth effect of the given dose had then ceased. Only the size of the degenerative cell was still greater than in the controls (Figs. 1 and 2 ). The degenerative cells determined at this time are the result of an earlier pro¬ liferation process initiated by growth hormone, ff the withdrawal period had been longer, the cells would probably have reached the same value as for the controls.
The time necessary to achieve maximum accumulated growth in length after the withdrawal of growth hormone administration may depend on the dose given and the period of administration. The effect of the endogenous pro¬ duction of growth hormone by the pituitary is much higher than the dose given in the present investigation, which in a previous investigation (Thorngren et al. 1973 ) has shown a significant growth promoting effect in hypophysectomized rats. As shown in the present investigation, the effect of the given dose on the longitudinal bone growth terminated within a 5-day period after the with¬ drawal of growth hormone administration. Previously, it was found that un¬ treated rats had a low basal growth rate within 10 days after hypophysectomy (Thorngren et al. 1973ß ). Thus, a 10-day period after the withdrawal of the growth hormone administration seemed to be sufficient to obtain a maximum effect on the accumulated growth in length of any administered dose of growth hormone.
The rate of longitudinal bone growth is equal to the product of two factors in the growth plate: the rate of production of new cells per column and the size of the degenerative cell (Sissons 1955; Walker 8c Rember 1972; Hansson, in press). The changes in the size of the degenerative cell found in the present investigation were minor. Thus, the changes in longitudinal bone growth found were predominantly due to changes in the accumulated cell pro¬ duction (Fig. 1 ). This agrees with earlier investigations (Thorngren 8c Hansson, in press). The small but insignificant variation in the degenerative cell size during the growth hormone administration, and following the withdrawal periods relevant to this investigation, indicates that any of the values of the degenerative cell size can be used for the calculation of cell production.
It has been claimed that the rate of longitudinal bone growth is directly proportional to the width of the growth plate (Rang 1969) . In the present in¬ vestigation, this relation was not found, nor was it found under experimental conditions in earlier investigations (Sissons 1956; Rember 1972; Hansson 1973a and in press). In normal animals, however, there is a relation between the width of the growth plate and the rate of bone growth (Thorngren 8c Hansson, in press).
The continued growth effect found in the present investigation after with¬ drawal of growth hormone administration may be caused by a depot effect of growth hormone and a delayed effect in the endochondral growth process.
In the present investigation, a depot effect of the administered growth hor¬ mone might have produced the continued longitudinal bone growth found after withdrawal of growth hormone administration. However, the injected volumes are small (0.1 ml) and would be resorbed rather quickly, so this effect is probably very small, since immunological determination of im injected human growth hormone in man has shown a peak in the serum concentration at about 3 h after the injection and undetectable concentration at about 24 h after the administration (Frasier et al. 1969 ). Furthermore, the half time for growth hormone in plasma is known to be about 30 min when determined immunologically (Click et al. 1964 ).
The delayed effect in the endochondral growth process seems most probable. In this process, the cartilage cells are stimulated to mitotic division by growth hormone, probably indirectly through the production of somatomedin (Rigai 1964; Rember 1971; Daughaday et al. 1972 ). As shown with sulphate incor¬ poration studies in vivo in hypophysectomized mice given ip injection of ovine growth hormone, there is a time-lag in the sulphation activity after a single dose, and the effect is maintained in vivo for at least 38 h after a single dose of growth hormone (Herbai 1971 (Greenspan et al. 1949) where the growth hormone-dependent in¬ crease in the width of the cartilage growth plate is used as bioassay for growth hormone, the growth plate decreases in width again after the withdrawal of growth hormone administration. A continued growth effect after withdrawal of the growth hormone administration, as shown in the present investigation, has not previously been observed.
The withdrawal effect found in the present investigation, with tetracycline as intravital marker of the longitudinal bone growth, can be used to increase the growth response in the bioassay of growth hormone. By this means the full effect of a dose of growth hormone is recorded, and the total number of cells produced by the dose can be calculated.
